Context Therapeutics Inc
F:6K9
Context Therapeutics Inc
F:6K9
Price:
2.38
EUR
0.85%
Market Closed
Market Cap:
€178.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Context Therapeutics Inc
F:6K9
|
US |
|
Volvo AB
OTC:VOLVF
|
SE |
|
S
|
Siemens AG
OTC:SMAWF
|
DE |
|
N
|
News Corp
F:NC0
|
US |
|
M
|
Middleby Corp
F:MBY
|
US |
|
D
|
Direct Line Insurance Group PLC
F:D1LN
|
UK |
|
Alfen NV
F:703
|
NL |
|
M
|
MM Forgings Ltd
BSE:522241
|
IN |
|
G
|
Garden Reach Shipbuilders & Engineers Ltd
BSE:542011
|
IN |
|
M
|
Macy's Inc
SWB:FDO
|
US |
|
A
|
Automatic Data Processing Inc
XETRA:ADP
|
US |
|
A
|
Aurinia Pharmaceuticals Inc
F:IKAP
|
CA |
|
A
|
Asana Inc
F:A6N
|
US |
|
I
|
IHI Corp
OTC:IHICF
|
JP |
|
ForFarmers NV
OTC:FRFBF
|
NL |
|
P
|
Power Corporation of Canada
XBER:PCR
|
CA |
|
Jyske Bank A/S
CSE:JYSK
|
DK |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of 6K9.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
6K9
Multiples-Based Value
Not Available
